ARS Pharmaceuticals Inc (NASDAQ: SPRY) Continues To Thrive In 2024, As Its Stock Is Up 156.39% Year-To-Date
During the last session, ARS Pharmaceuticals Inc (NASDAQ:SPRY)’s traded shares were 1.13 million, with the beta value of the company hitting 0.89. At the end